eCommons@AKU
Community Health Sciences

Department of Community Health Sciences

12-17-2020

Maternal mortality in six low and lower-middle income countries
from 2010 to 2018: Risk factors and trends
Melissa Bauserman
Vanessa R. Thorsten
Tracy L. Nolen
Jackie Patterson
Adrien Lokangaka

See next page for additional authors

Follow this and additional works at: https://ecommons.aku.edu/pakistan_fhs_mc_chs_chs
Part of the Female Urogenital Diseases and Pregnancy Complications Commons, Maternal and Child
Health Commons, Obstetrics and Gynecology Commons, and the Women's Health Commons

Authors
Melissa Bauserman, Vanessa R. Thorsten, Tracy L. Nolen, Jackie Patterson, Adrien Lokangaka, Antoinette
Tshefu, Archana B. Patel, Patricia L. Hibberd, Sarah Saleem, and Saleem Jessani

Bauserman et al. Reproductive Health 2020, 17(Suppl 3):173
https://doi.org/10.1186/s12978-020-00990-z

RESEARCH

Open Access

Maternal mortality in six low and lowermiddle income countries from 2010 to
2018: risk factors and trends
Melissa Bauserman1* , Vanessa R. Thorsten2, Tracy L. Nolen2, Jackie Patterson1, Adrien Lokangaka3,
Antoinette Tshefu3, Archana B. Patel4,5, Patricia L. Hibberd6, Ana L. Garces7, Lester Figueroa7, Nancy F. Krebs8,
Fabian Esamai9, Paul Nyongesa9, Edward A. Liechty10, Waldemar A. Carlo11, Elwyn Chomba12,
Shivaprasad S. Goudar13, Avinash Kavi13, Richard J. Derman14, Sarah Saleem15, Saleem Jessani15,
Sk Masum Billah16,17, Marion Koso-Thomas18, Elizabeth M. McClure2, Robert L. Goldenberg19 and Carl Bose1
From Global Network
Virtual. 3-15 Septemeber 2020

Abstract
Background: Maternal mortality is a public health problem that disproportionately affects low and lower-middle
income countries (LMICs). Appropriate data sources are lacking to effectively track maternal mortality and monitor
changes in this health indicator over time.
Methods: We analyzed data from women enrolled in the NICHD Global Network for Women’s and Children’s
Health Research Maternal Newborn Health Registry (MNHR) from 2010 through 2018. Women delivering within
research sites in the Democratic Republic of Congo, Guatemala, India (Nagpur and Belagavi), Kenya, Pakistan, and
Zambia are included. We evaluated maternal and delivery characteristics using log-binomial models and
multivariable models to obtain relative risk estimates for mortality. We used running averages to track maternal
mortality ratio (MMR, maternal deaths per 100,000 live births) over time.
Results: We evaluated 571,321 pregnancies and 842 maternal deaths. We observed an MMR of 157 / 100,000
live births (95% CI 147, 167) across all sites, with a range of MMRs from 97 (76, 118) in the Guatemala site to
327 (293, 361) in the Pakistan site. When adjusted for maternal risk factors, risks of maternal mortality were
higher with maternal age > 35 (RR 1.43 (1.06, 1.92)), no maternal education (RR 3.40 (2.08, 5.55)), lower
education (RR 2.46 (1.54, 3.94)), nulliparity (RR 1.24 (1.01, 1.52)) and parity > 2 (RR 1.48 (1.15, 1.89)). Increased
risk of maternal mortality was also associated with occurrence of obstructed labor (RR 1.58 (1.14, 2.19)), severe
antepartum hemorrhage (RR 2.59 (1.83, 3.66)) and hypertensive disorders (RR 6.87 (5.05, 9.34)). Before and after
adjusting for other characteristics, physician attendance at delivery, delivery in hospital and Caesarean delivery
were associated with increased risk. We observed variable changes over time in the MMR within sites.
(Continued on next page)
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Conclusions: The MNHR is a useful tool for tracking MMRs in these LMICs. We identified maternal and
delivery characteristics associated with increased risk of death, some might be confounded by indication.
Despite declines in MMR in some sites, all sites had an MMR higher than the Sustainable Development Goals
target of below 70 per 100,000 live births by 2030.
Trial registration: The MNHR is registered at NCT01073475.
Keywords: Low-resource countries, Maternal mortality, Sustainable development goals, Global network

Plain English summary
Reducing maternal mortality is a global health priority.
Maternal mortality disproportionately affects women in
low and lower-middle income countries, and many of
these deaths are preventable. We describe maternal
death in research sites in the Democratic Republic of
Congo, Guatemala, India (Nagpur and Belagavi), Kenya,
Pakistan, and Zambia. We emphasize that the number of
women dying in these countries is higher than the targets set out in the World Health Organization’s Sustainable Development Goals for 2030. We describe large
differences between countries in terms of the ratio of
maternal death. We identify maternal and delivery characteristics associated with increased risk of death, although some of the characteristics might be influenced
by other factors.

defined variables and weakly justified assumptions
that lead to low precision in the final results [10, 12].
Therefore, primary datasets that reliably track the
MMR in LMICs are urgently needed to provide a
more robust evidence base for evaluating and tracking
maternal mortality [13].
In this manuscript, we describe maternal mortality in
6 LMICs from a defined geographic, community-based,
prospectively collected maternal health registry that captures data on all women delivering within or outside of
facilities. This longitudinal dataset describes maternal
deaths over a 9-year period. We examine maternal characteristics associated with maternal deaths, causes of
maternal death and evaluate site specific trends in the
MMR over time.

Background
Reducing maternal mortality is a global health priority. The Sustainable Development Goals (SDGs) aim
for a reduction of the maternal mortality ratio
(MMR) to below 70 per 100,000 live births by 2030
[1]. If the SDGs are met by 2030, the lives of an estimated 1.6 million mothers will be saved [2]. Maternal
mortality is not only a health indicator, but also a key
indicator of country development because maternal
deaths have an important social and economic impact
[3–5]. Maternal mortality disproportionately affects
women in low and lower-middle income countries
(LMICs) where most of the maternal deaths are from
preventable causes [6].
Despite the majority of maternal deaths occurring
in LMICs (MMR of 479 for low income countries
compared to 41 in high income countries), robust
systems for data collection and health indicator tracking are lacking [7]. This makes reliable tracking of
MMRs difficult, despite global attention to the problem [8]. Also, controversy still exists regarding the
optimal way to monitor maternal mortality [9]. In
areas where health registries are lacking, the MMR
can be estimated through a series of modelling strategies which rely on local data sources [8, 10, 11].
When data are sparse, such as in LMICs, these strategies rely on complex models with several poorly

Methods
We analyzed data from the Eunice Kennedy Shriver
National Institute of Child Health and Human Development (NICHD) Global Network (GN) for Women’s
and Children’s Health Research Maternal Newborn
Health Registry (MNHR) [14]. The MNHR is a multicountry pregnancy registry including research sites in
the Democratic Republic of Congo (DRC; North and
South Ubangi Provinces); Guatemala (Western Highlands); India (Belagavi and Nagpur); Kenya (Western
region); Pakistan (near the city of Karachi); and
Zambia (south and east of the capital city of Lusaka).
The study population includes both peri-urban and
rural settings.
We included all pregnancies from January 2010 to
December 2018, expanding on previously published
results from 2010 to 2013 [15]. MNHR data, were
collected from pregnant women who reside in or deliver within study clusters through various methods,
including detailed interviews conducted by trained
study staff, as well as abstraction from medical records. Women were identified for inclusion as early
as possible during their pregnancy, then screened and
consented. We collected baseline maternal characteristics at the time of entry into the registry. Additional
antenatal and delivery characteristics were recorded
within 3–7 days of delivery and postpartum details
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were collected at home or clinic visits 6 weeks after
delivery. We excluded women who were lost to follow
-up prior to delivery or those with missing data on
maternal status at 42 days after the end of the
pregnancy.
We defined maternal death in accordance with the
World Health Organization definition of death of the
mother while pregnant or within 42 days of the end
of the pregnancy. We defined MMR as maternal
deaths/100,000 live births. To calculate the MMR, we
included all maternal deaths, regardless of the birth
outcome (miscarriage, stillbirth, medical termination
of pregnancy [MTP], live birth and unknown birth
outcomes) in the numerator. The denominator is live
born infants. The 95% confidence interval for the
MMR is approximated using the variance of the proportion of maternal deaths for each site and year. We
defined fetal malposition as transverse lie, oblique lie
or breech presentation.
We explored the relationship between characteristics and overall mortality using log-binomial generalized linear models with generalized estimating
equations to obtain point and interval estimates of
risk ratios for mortality modeled as a function of each
characteristic independently while controlling for the
correlation within clusters. For the purpose of the
models, we evaluated the outcome of maternal death
vs. women who survived to 42 days after the end of
pregnancy. We included women who experienced all
birth outcomes (miscarriage, stillbirth, live birth and
unknown birth outcomes) in the models. Women
without the characteristic (e.g. labor not obstructed)
served as the reference group.
Next, we ran a multivariable regression model to determine the maternal, pregnancy related, delivery and
antepartum factors that were associated with maternal
death. Medical and social variables collected at the time
of enrollment or around the time of delivery that could
be associated with maternal mortality and were reliably
collected in the MNHR were included. We included:
maternal age, maternal education, parity, antenatal care
(ANC), birth attendant, delivery mode, obstructed labor,
fetal malposition, hemorrhage and hypertensive disorders. We defined severe antepartum hemorrhage as
blood loss greater than 1000 cm3 (cc) of blood prior to
delivery. Factors with significant missing fields were excluded. We adjusted the model further for research site
and accounted for correlation of outcomes within clusters. Data are presented as adjusted risk ratios and 95%
confidence intervals. In 2013, the MNHR began assigning cause of maternal deaths by collecting data describing factors associated with deaths. We assigned a cause
of death from these data using a standardized, hierarchical, algorithm [16].
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The MNHR had some notable differences in its
population over time. The DRC site entered the
MNHR in 2014. Throughout the 9-year study period,
there was expansion and contraction of clusters
within each country to meet the research needs of
the GN. In order to limit external forces that might
alter the study population by inclusion of different
clusters, we described the MMR over time using a
subset of data. This subset included only GN clusters that were consistent throughout the 9-year
period in the Guatemala, India (Nagpur and
Belagavi), Kenya, Pakistan, and Zambia sites. For the
DRC site, we included women who lived in clusters
that remained in the registry from 2014 to 2018. Because of the small number of maternal deaths and
the variation in the MMR from year to year, we
evaluated the MMR in overlapping periods of 3
years. This approach permitted evaluation using a
running average. Because data are not available from
the DRC site throughout the entire period of analysis, we report the total MMR with data from the
DRC site included and excluded.
The Data Coordinating Center at RTI International
(Durham, NC) performed all analyses using SAS, Inc.
(Version 9.4). Institutional Review Boards or research
ethics committees and Ministries of Health at each site
approved the collection of data included in the MNHR.
Prior to the initiation of data collection, we used
sensitization meetings to gain local approval of study
procedures at the community level. Individual participants gave informed consent. The NICHD appointed a
data monitoring committee to annually review the
MNHR.

Results
We screened 582,768 women for inclusion in the
MNHR from 2010 to 2018. Of those screened, 579,140
(99.4%) were eligible and consented to be part of the
MNHR, (Fig. 1). Of women who consented, 7819
(1.3%) were lost to follow up, leaving 571,321 (98.6%)
for analysis. These pregnancies resulted in 576,685
outcomes (including multiple gestations): 19,080 (3%)
miscarriages, 14,432 (3%) stillbirths, 7789 (1%) MTPs,
225 (< 0.1%) unknown birth outcomes and 535,159
(93%) live births (Table 1). We included data on 842
maternal deaths: 452 (53%) of the birth outcomes of
the women who died were live births, 182 (21%) were
stillbirths, 7 (< 1%) were miscarriages, 3 (< 1%) were
MTPs, and 219 (25%) had unknown birth outcomes.
Thus, of the 75% of cases where fetal or neonatal
outcome were known, more than 20% were associated
with stillbirth. We observed an MMR of 157 / 100,000
live births (95% CI 147, 167), with a range of MMRs from
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Screened (N=582,768)
Ineligible (N=2,543)
Did not consent (N=1,085)

Eligible and Consented
(N=579,140)

Lost to follow-up before delivery (N=5,992)

Delivered (N=573,148)
Lost to Follow-Up after delivery (N=1,827)

Population analyzed
(N=571,321)
Fig. 1 Enrollment Diagram

97 (76, 118) in the Guatemala site to 327 (293, 361) in the
Pakistan site.
We evaluated maternal characteristics associated
with maternal death (Table 2). Women who were
older than 35 years of age, those with no formal or
only primary/secondary education compared to university or higher education, nulliparous or multiparous with > 2 pregnancies, compared to 1–2 prior
pregnancies and those whose last pregnancy did not
result in a live birth were at an increased risk for maternal death. Antenatal and delivery characteristics
that were associated with an increased risk of maternal death included: limited or no ANC, hospital delivery,
delivery by a physician, assisted vaginal or Caesarean delivery, obstructed labor, fetal malpresentation, severe antepartum hemorrhage (> 1000 cc blood loss), hypertensive

disorders and intrapartum medical treatments such as antibiotics, corticosteroids, blood transfusions, removal of
retained products, anticonvulsant medications, IV fluids,
use of forceps/vacuum, and other surgeries or treatments
(Table 3).
We evaluated selected factors and their association
with maternal death using a multivariable model
(Table 4). We included site, maternal, antenatal and
delivery characteristics in the model to determine the
relationship with maternal mortality. After adjusting
for differences in characteristics, we found the same
direction and similar magnitude of association for
age, education and parity. Obstructed labor, severe
antepartum hemorrhage, and hypertensive disorders
also still had an increased risk of death. However,
when adjusted for other factors, malpresentation and

Table 1 Overall pregnancy outcomes by site, 2010–2018, all clustersa
Characteristic

Overall,
all sites

Democratic
Guatemala Belagavi
Republic of Congo

Nagpur

Kenya

Pakistan

Zambia

Pregnancies, n

571,321

31,896

83,320

135,384

87,395

73,904

96,760

62,662

Miscarriages, n

19,080

244

694

8280

3322

210

5877

453

Medical Termination 7789
of Pregnancy, n

83

1

4362

1993

33

1303

14

Unknown birth
outcomes, n

225

30

10

37

38

23

71

16

Stillbirths, n

14,432

1239

1522

3002

1775

1554

4164

1176

Live births, n

535,159

30,870

81,672

120,629

80,917

72,973

86,458

61,640

Maternal deaths, n

842

98

79

149

89

78

283

66

b

Total MMR(95% CI)
a

157 (147, 167) 317 (257, 378)

97 (76, 118) 124 (106, 141) 110 (89, 131) 107 (83, 130) 327 (293, 361) 107 (82, 132)

Maternal Newborn Health Registry 2010–2018 deliveries, excluding women lost to follow-up prior to delivery or missing maternal status at 42 days
b
Maternal Mortality Ratio (MMR) is maternal deaths per 100,000 live births. The 95% confidence interval for the MMR is approximated using the variance of the
proportion of maternal deaths for each site and year
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Table 2 Maternal characteristics by maternal status at 42 days after delivery, 2010–2018 all clusters
Characteristica

Deliveries, N
Maternal age
< 20

N(%) by maternal status

Total

Women who died

Women alive six
weeks after delivery

842

570,479

Risk Ratio(95% CI)b

571,321

839

569,478

570,317

65 (7.7)

71,758 (12.6)

71,823 (12.6)

0.7 (0.5, 0.9)

20–35

695 (82.8)

471,940 (82.9)

472,635 (82.9)

1.0

> 35

79 (9.4)

25,780 (4.5)

25,859 (4.5)

2.0 (1.6, 2.5)

841

568,765

569,606

360 (42.8)

137,325 (24.1)

137,685 (24.2)

Maternal education
No formal education

3.8 (2.6, 5.6)

Primary/Secondary

458 (54.5)

391,879 (68.9)

392,337 (68.9)

1.9 (1.3, 2.8)

University +

23 (2.7)

39,561 (7.0)

39,584 (6.9)

1.0

836

566,711

567,547

238 (28.5)

183,868 (32.4)

184,106 (32.4)

Parity
0

1.2 (1.0, 1.4)

1–2

273 (32.7)

240,049 (42.4)

240,322 (42.3)

1.0

>2

325 (38.9)

142,794 (25.2)

143,119 (25.2)

1.7 (1.5, 2.1)

56/598 (9.4)

21,148/382,772 (5.5)

21,204/383,370 (5.5)

1.7 (1.3, 2.3)

Last pregnancy did not result in a live birth
a

The denominator used to determine the percentage of women with each characteristic varies due to missing data
b
Risk ratios were generated from models evaluating the outcome of women who died vs women who were alive six weeks after delivery. Generalized linear
models were used to evaluate the relationship of potential factors and maternal mortality and to develop point and interval estimates of relative risk associated
with these factors. Generalized estimating equations were used to account for the correlation of outcomes within cluster to develop appropriate confidence
intervals. Unless otherwise noted, the reference group is women who did not have the listed characteristic

ANC were no longer associated with risk of death. Of
note, delivery location, birth attendance and delivery
mode remained significant in the model. However,
while physician delivery was still associated with an
increased risk of maternal mortality compared to delivery by a nurse/midwife/health worker, it no longer
had an increased observed risk compared to traditional birth attendants or family/self/other (RR confidence intervals include 1). Likewise, delivery in a
hospital retained a significant association with increased
maternal mortality compared to delivery in a clinic/health
center, but not compared to home/other. Lastly, while
caesarean delivery still showed an association with increased risk of maternal mortality compared to vaginal delivery, vaginal assisted delivery did not.
We identified hemorrhage (33%), infection (31%) and
pre-eclampsia/eclampsia (16%) as the most common
causes of maternal death overall in our population
(Table 5). The primary causes of death varied by site
and we observed wide site differences in the percentage
of deaths attributable to these causes.
Of the overall study population, we included 466,772
(81.7%) for analysis of trends in the MMR over time
(Table 6). The total MMR in the ongoing clusters
was 158 (147, 169). When we excluded the DRC site
from the overall MMR trend, we observed variance in
the MMR from 130 (112, 148) to 159 (139, 178). We
observed site variation of MMR over time (Fig. 2).

The Zambia site varied in the 3 year running averages
from 141 (91, 192) in the earliest interval to 72 (36, 108)
in the latest interval. The Kenya site varied from 133
(90, 176) in the earliest interval to 103 (61,144) in the
latest interval. The Pakistan site 3 year running averages ranged from 336 (265, 408) to 404 (321, 488).
The sites in Guatemala, Belagavi and Nagpur, India
had similar MMR from the beginning to the end of
the study period. Only 5 years of data were available
for the DRC, and the MMR varied little from 289
(213, 365) to 294 (220, 329).

Discussion
Our data show an MMR higher than the SDG 2030
goals in all research sites within the NICHD GN. We
measured an MMR of 157 / 100,0000 live births,
which is more than double the SDG target of less
than 70 per 100,000 live births by 2030. There is
great variation in MMR across sites, with the lowest
average MMRs during the study period in the
Guatemala (97), Kenya (107) and Zambia (107) sites
to the highest MMRs measured in the DRC (317) and
Pakistan (327) sites. We identified maternal, antenatal
and delivery characteristics that were associated with
maternal death. We identified hemorrhage, infection
and pre-eclampsia/eclampsia as the most common
causes of maternal death. Of the 75% of cases where
fetal or neonatal outcome were known, more than
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Table 3 Antenatal and delivery characteristics by maternal status at 42 days after delivery, 2010–2018 all clusters
Characteristica

Deliveries, N

N(%) by maternal status
Women who died

Women alive six weeks
after delivery

842

570,479

Total

Risk Ratio(95% CI)b

571,321

No antenatal care (vs. any antenatal care)

62/834 (7.4)

20,426/570,105 (3.6)

20,488/570,939 (3.6)

1.6 (1.1, 2.4)

Fewer than 4 antenatal care visits (vs. > 4 visits)

339/605 (56.0)

201,105/447,076 (45.0)

201,444/447,681 (45.0)

1.3 (1.1, 1.7)

Birth attendant
Physician

620

570,351

570,971

291 (46.9)

203,294 (35.6)

203,585 (35.7)

1.0

Nurse/Midwife/Health worker

131 (21.1)

203,325 (35.6)

203,456 (35.6)

0.4 (0.3, 0.5)

Traditional birth attendant

134 (21.6)

119,738 (21.0)

119,872 (21.0)

0.5 (0.4, 0.7)

Family/Self/Other

64 (10.3)

43,994 (7.7)

44,058 (7.7)

0.8 (0.6, 1.0)

623

570,402

571,025

Delivery location
Hospital

335 (53.8)

244,926 (42.9)

245,261 (43.0)

1.0

Clinic/health center

113 (18.1)

170,980 (30.0)

171,093 (30.0)

0.4 (0.3, 0.5)

Home/other

175 (28.1)

154,496 (27.1)

154,671 (27.1)

0.6 (0.5, 0.8)

612

545,759

546,371

Vaginal

424 (69.3)

466,355 (85.5)

466,779 (85.4)

1.0

Vaginal assisted

19 (3.1)

5364 (1.0)

5383 (1.0)

3.3 (1.7, 6.5)

Delivery mode

169 (27.6)

74,040 (13.6)

74,209 (13.6)

2.7 (2.3, 3.3)

Obstructed labor

Caesarean section

148/697 (21.2)

44,947/569,869 (7.9)

45,095/570,566 (7.9)

3.0 (2.3, 3.9)

Fetal Malpresentation

45/692 (6.5)

11,253/569,773 (2.0)

11,298/570,465 (2.0)

3.3 (2.4, 4.4)

Severe antepartum hemorrhage

71/695 (10.2)

8783/569,937 (1.5)

8854/570,632 (1.6)

6.7 (5.0, 9.0)

Hypertensive disorders

156/688 (22.7)

14,650/569,679 (2.6)

14,806/570,367 (2.6)

10.6 (8.5, 13.2)

Maternal antibiotics

350/559 (62.6)

229,932/464,473 (49.5)

230,282/465,032 (49.5)

2.3 (1.8, 2.9)

Corticosteroids

43/439 (9.8)

10,225/413,905 (2.5)

10,268/414,344 (2.5)

4.0 (2.8, 5.9)

Oxytocics (including Misoprostol)

344/556 (61.9)

308,315/463,555 (66.5)

308,659/464,111 (66.5)

0.9 (0.7, 1.1)

Blood transfusion

186/560 (33.2)

9789/464,309 (2.1)

9975/464,869 (2.1)

20.9 (16.0, 27.2)

Removal of retained products

45/558 (8.1)

20,750/464,252 (4.5)

20,795/464,810 (4.5)

2.1 (1.4, 3.1)

Anticonvulsants/Magnesium sulfate

60/553 (10.8)

5692/464,277 (1.2)

5752/464,830 (1.2)

9.8 (7.2, 13.4)

Maternal treatment provided

V Fluids

182/258 (70.5)

90,672/173,017 (52.4)

90,854/173,275 (52.4)

2.4 (1.7, 3.4)

Forceps/vacuum

13/254 (5.1)

1908/172,354 (1.1)

1921/172,608 (1.1)

4.3 (2.4, 7.7)

Other surgery/treatment

22/255 (8.6)

9830/172,810 (5.7)

9852/173,065 (5.7)

1.7 (1.1, 2.7)

a

The denominator used to determine the percentage of women with each characteristic varies due to missing data
b
Risk ratios were generated from models evaluating the outcome of women who died vs women who were alive six weeks after delivery. Generalized linear
models were used to evaluate the relationship of potential factors and maternal mortality and to develop point and interval estimates of relative risk associated
with these factors. Generalized estimating equations were used to account for the correlation of outcomes within cluster to develop appropriate confidence
intervals. Unless otherwise noted, the reference group is women who did not have the listed characteristic

20% were associated with stillbirth. We observed
some sites with improvement in the MMR over time,
but the Pakistani site reported an increase in the
MMR over time.
When compared to the World Bank modeled estimates for the MMR by country, our data indicate a
lower MMR for the sites in all countries, except
Pakistan [17]. For example, we measured an MMR
of 317 in the DRC site, compared to the World

Bank estimates of 850, and we measured an MMR of
107 in the Zambia site, compared to the World Bank
estimate of 398 [7]. The World Bank estimates are
developed from representative samples of the populations across countries in contrast to our MMR
which measures outcomes in a region within the
country. Our data are collected at the individual
level within a discrete population within each country. It might not be representative of the entire
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Table 4 Multivariable model of maternal status at 42 days after
delivery controlling for site, maternal, antenatal and delivery
characteristics, 2010–2018 all clusters
Characteristic

Overall p-valuea

Maternal age

0.0017

< 20

Risk Ratio
(95% CI)a
0.64 (0.45, 0.89)

20–35

1.0

> 35

1.43 (1.06, 1.92)

Maternal education

<.0001

No formal education

3.40 (2.08, 5.55)

Primary/Secondary

2.46 (1.54, 3.94)

University +

1.0

Parity

0.0031

0

1.24 (1.01, 1.52)

1–2

1.0

>2

1.48 (1.15, 1.89)

At least one antenatal care visit

0.1707

Birth attendant

<.0001

1.22 (0.92, 1.61)

Physician

1.0

Nurse/Midwife/Health worker

0.61 (0.45, 0.84)

Traditional birth attendant

0.74 (0.50, 1.10)

Family/Self/Other

1.38 (0.91, 2.09)

Delivery location

<.0001

Hospital

1.0

Clinic/health center

0.57 (0.44, 0.75)

Home/other

0.89 (0.62, 1.28)

Delivery mode

0.0048

Vaginal

1.0

Vaginal assisted

1.58 (0.80, 3.12)

Caesarean section

1.60 (1.21, 2.13)

Obstructed labor

0.0062

1.58 (1.14, 2.19)

Fetal Malpresentation

0.1140

1.30 (0.94, 1.79)

Severe antepartum hemorrhage

<.0001

2.59 (1.83, 3.66)

Hypertensive disorders

<.0001

6.87 (5.05, 9.34)

a

A generalized linear model was used to evaluate the relationship of potential
factors and maternal mortality and to develop point and interval estimates of
relative risk associated with these factors after controlling for site and all other
listed characteristics. Generalized estimating equations were used to account
for the correlation of outcomes within cluster to develop appropriate
confidence intervals. Unless otherwise noted, the reference group is women
who did not have the listed characteristic

population of the diverse countries in which we
work. For example, our data from the rural provinces in the DRC are likely not reflective of the
population in the urban capital of Kinshasa. However, we do not believe that this variation in methodology entirely accounts for the wide discrepancies we
have observed. We presume these data highlight the
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differences between data measured prospectively in a
direct fashion, compared to indirect measurements
and estimates derived from modelling strategies with
unknown reliability.
We describe an increased risk of maternal death
among women who deliver in hospitals, those who
have deliveries attended by physicians and those who
deliver by Caesarean section. We presume that the
women who seek care by a physician or in a hospital
are at higher risk for pregnancy complications or have
experienced pregnancy complications that have required a higher level of medical care. Therefore, we
believe that these associations are confounded by indication. This presumption is consistent with previous
literature that indicates that the largest proportion of
maternal deaths occur in facilities where the higher
risk patients are treated and where complicated patients are referred [18]. Ronsmans and colleagues describe three categories of women who die in
hospitals: women who arrive in a moribund state too
late to benefit from emergency medical treatment,
high risk women who could have been saved if they
received timely and effective interventions and women
who develop serious complications within the hospital
[18]. While our data are consistent with findings that
hospital delivery is associated with higher maternal
mortality, we do not have data on the quality of care
that was delivered to these women or at what point
in the mother’s illness she arrived at the hospital for
care.
The MNHR represents a useful tool for recording
and tracking the MMR in several LMICs. Our data
are rigorously collected in a prospective fashion with
consistent methodology over a long period of time.
Because we collect data from all pregnant women
living in a geographic area, regardless of delivery
site, the MNHR is ideal for giving an accurate account of the MMR in the population studied. The
MNHR has a high rate of recruitment and retention
(outcomes obtained on 98.6% of women) which provides robust data for studying maternal and neonatal
outcomes through 6 post-partum weeks, referenced
elsewhere in the supplement. Furthermore, the
MNHR contains data from a consistent population
of women in LMICs over a 9-year period. This ongoing data collection tool is ideal for examining
trends in health outcomes within study regions over
time.
The MNHR does have some practical limitations.
Women can be enrolled in the MNHR at any point in
their pregnancy, so we potentially underrepresent maternal death that occurs early in pregnancy that could be
related to miscarriages or MTPs. Our analyses are also
limited to the variables that are collected within the
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Table 5 Cause of maternal death by site, all clusters
Characteristic

Overall

DRC

Guatemala

Belagavi

Nagpur

Kenya

Pakistan

Zambia

Maternal deathsa, n

842

98

79

149

89

78

283

66

Maternal cause of death data availableb, n (%)

436 (51.8)

97 (99.0)

46 (58.2)

50 (33.6)

43 (48.3)

35 (44.9)

139 (49.1)

26 (39.4)

Maternal cause of death, n (%)

436

97

46

50

43

35

139

26

Trauma

22 (5.0)

4 (4.1)

2 (4.3)

4 (8.0)

2 (4.7)

5 (14.3)

3 (2.2)

2 (7.7)

Abortion related

21 (4.8)

6 (6.2)

1 (2.2)

1 (2.0)

2 (4.7)

6 (17.1)

4 (2.9)

1 (3.8)

Preeclampsia/ Eclampsia

69 (15.8)

10 (10.3)

16 (34.8)

8 (16.0)

5 (11.6)

10 (28.6)

15 (10.8)

5 (19.2)

Hemorrhage

144 (33.0)

41 (42.3)

14 (30.4)

16 (32.0)

13 (30.2)

8 (22.9)

44 (31.7)

8 (30.8)

Infection

136 (31.2)

18 (18.6)

13 (28.3)

20 (40.0)

13 (30.2)

2 (5.7)

63 (45.3)

7 (26.9)

Medical condition coincident to pregnancy

23 (5.3)

9 (9.3)

0 (0.0)

1 (2.0)

4 (9.3)

1 (2.9)

6 (4.3)

2 (7.7)

Unknown

21 (4.8)

9 (9.3)

0 (0.0)

0 (0.0)

4 (9.3)

3 (8.6)

4 (2.9)

1 (3.8)

a

Maternal Newborn Health Registry (MNHR) 2010–2018 deliveries, excluding women lost to follow up prior to delivery or missing maternal status at 42 days
Maternal cause of death data collected from late 2013 to 2018. Cause of death determined by a standardized, heirarchical algorithm [16] in which one cause of
death is identified, therefore, categories are mutually exclusive
b

MNHR. For example, the causes of maternal death are
estimates using interview techniques and medical chart
extraction. Supportive laboratory data were rarely available and autopsies were not performed. As such, these
data were not included in the cause of death algorithm
[16]. Additionally, sites that do not routinely measure
blood pressures as part of ANC, report lower rates of
pre-eclampsia/eclampsia. However, despite these biases,
our approach to identify causes of death found similar
relative contributions to other published reports. Therefore, our approach might represent an opportunity to
identify maternal health practices that could prevent
specific causes of mortality [19, 20].

Conclusions
The results of our study contribute important MMR
data in 6 LMICs. The differences that we described,
compared to MMRs from modelling estimates, illustrate the vast variation in MMR estimates given the
data source and strategy used. Because our data are
collected prospectively, we believe that the MNHR is
an ideal source for evaluating key health outcomes.
The high, but relatively stable, MMR in many countries highlights an opportunity for improvement in
these countries. While the Guatemalan and Zambian
sites have demonstrated success in lowering the
MMR over the study period, sites in other countries,

Table 6 Trend in maternal mortality ratio by site and combined years, 2010–2018 in ongoing clustersa
Characteristic

Overall, all sites

Overall,
excluding DRC

DRC

Guatemala

Belagavi

Nagpur

Kenya

Pakistan

Zambia

Births, n

466,772

434,876

31,896

60,434

88,684

84,241

73,904

64,951

62,662

Maternal deaths, n

694

596

98

69

95

84

78

204

66

Ongoing clustersa

Deliveries, n

471,272

438,806

32,466

60,832

89,300

84,872

74,793

65,710

63,299

Live births, n

438,855

407,985

30,870

59,198

78,265

77,968

72,973

57,941

61,640

Total MMR(95% CI)a

158 (147, 169)

146 (135, 157)

317 (257, 378)

117 (90, 143)

121 (100, 143)

108 (86, 129)

107 (83, 130)

352 (309, 395)

107 (82, 132)

141 (91, 192)

MMR, maternal deaths per 100,000 live births (95% CI))b
2010–2012

159 (139, 178)

159 (139, 178)

120 (68, 172)

135 (100, 170)

110 (74, 146)

133 (90, 176)

336 (265, 408)

2011–2013

151 (132, 169)

151 (132, 169)

110 (63, 158)

124 (91, 158)

99 (64, 134)

114 (74, 154)

374 (299, 450)

124 (76, 172)

2012–2014

139 (121, 158)

139 (121, 158)

119 (71, 168)

106 (73, 139)

108 (71, 144)

101 (62, 141)

326 (255, 397)

116 (69, 163)

2013–2015

130 (112, 148)

130 (112, 148)

106 (63, 150)

92 (59, 125)

106 (70, 142)

81 (45, 117)

323 (253, 393)

108 (63, 153)

2014–2016

149 (131, 168)

130 (112, 148)

289 (213, 365)

114 (70, 158)

82 (48, 115)

117 (79, 155)

92 (53, 131)

326 (255, 397)

77 (40, 114)

2015–2017

162 (143, 181)

143 (124, 162)

289 (215, 364)

130 (84, 176)

109 (70, 148)

97 (62, 132)

98 (58, 138)

386 (307, 465)

89 (50, 129)

2016–2018

168 (148, 188)

149 (129, 169)

294 (220, 369)

124 (79, 169)

136 (91, 181)

107 (69, 145)

103 (61, 144)

404 (321, 488)

72 (36, 108)

a
Maternal Newborn Health Registry 2010–2018 deliveries, excluding women lost to follow-up prior to delivery or missing maternal status at 42 days. Clusters
collecting data during the enti re period of 2010–2018, or 2014–2018 for DRC
b
Maternal Mortality Ratio (MMR) is maternal deaths per 100,000 live births. The 95% confidence interval for the MMR is approximated using the variance of the
proportion of maternal deaths for each site and year
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Fig. 2 Running average of maternal mortality ratio1 by site and years, 2010–2018 ongoing clusters2. 1 Maternal Mortality Ratio (MMR) is maternal
deaths per 100,000 live births. 2 Maternal Newborn Health Registry 2010–2018 deliveries excluding women lost to follow-up prior to delivery or
missing maternal status at 42 days. Clusters collecting data during the entire period of 2010–2018, or in the DRC where clusters collecting data
from 2014 to 2018 are represented. DRC is excluded from total, since data not known prior to 2014

like the DRC and Pakistan, had persistently high
MMRs at the end of the study period. Maternal mortality is an important public health problem and these
data confirm the opportunity for improvement.
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